CYRX News and Press, CryoPort Inc. From 02/08/23

Summary Cryoport has been punished over the last 12 months amid a number of downside catalysts. Shares have recently curled up off 52-week lows, asking the question on whether this is an appropriate time for entry. The company's upcoming FY22 numbers will be telling where the stock ...

Cryoport Announces New Strategic Partnership with Syneos Health to Advance Cell & Gene Therapies Cryoport Announces New Strategic Partnership with Syneos Health to Advance Cell & Gene Therapies PR Newswire Partnership to Provide Cell and Gene Industry Integrated ...

Cryoport to Present at the J.P. Morgan 41st Annual Healthcare Conference PR Newswire NASHVILLE, Tenn. , Dec. 20, 2022 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solut...

Cryoport, Inc. (CYRX) Q3 2022 Results Conference Call November 03, 2022 05:00 PM ET Company Participants Todd Fromer - Managing Partner-KCSA Jerrell Shelton - Chief Executive Officer Robert Stefanovich - Chief Financial Officer Dr. Mark Sawicki - Chief Scient...

Shares of Cryoport ( NASDAQ: CYRX ) sank 24.7% to $19.96 in Friday early trading, as the cold-storage logistics company reported a quarterly miss on both top and bottom line and slashed its FY 2022 revenue guidance. The stock was already on a two-day losing streak ...

CryoPort press release ( NASDAQ: CYRX ): Q3 GAAP EPS of -$0.15 misses by $0.01 . Revenue of $60.5M (+6.7% Y/Y) misses by $9.47M . The Company's revised revenue guidance for the full year 2022 is $232 - $238 million vs $260.66M Consensus. Share Repurchase: O...

Cryoport Reports Results for the Third Quarter 2022 PR Newswire Third quarter revenue of $60.5 million ; nine months 2022 revenue reaches $176.9 million ; Cryoport Systems' revenue up 25% year-over-year $530 million in cash and short-term investme...

Cryoport to Report Third Quarter 2022 Financial Results on November 3, 2022 PR Newswire NASHVILLE, Tenn. , Oct. 27, 2022 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chai...

Summary As a small logistics operator servicing other celllular therapy innovators, Cryoport is powered by the prudent merger/acquisition growth approach. Regardless of the bear market, Cryoport has been enjoying huge topline growth from successful acquisitions. Asides from bu...

Cold-storage logistics company Cryoport ( NASDAQ: CYRX ) on Thursday said it had entered into a strategic relationship with BioLife Plasma Services, part of Japanese pharmaceutical major Takeda ( TAK ), to establish a supply chain platform. CYRX and BioLife will aim to...